Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kei Kadoda"'
Selective cytotoxicity of the anti-diabetic drug, metformin, in glucose-deprived chicken DT40 cells.
Autor:
Kei Kadoda, Takahito Moriwaki, Masataka Tsuda, Hiroyuki Sasanuma, Masamichi Ishiai, Minoru Takata, Hiroshi Ide, Shin-Ichiro Masunaga, Shunichi Takeda, Keizo Tano
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185141 (2017)
Metformin is a biguanide drug that is widely used in the treatment of diabetes. Epidemiological studies have indicated that metformin exhibits anti-cancer activity. However, the molecular mechanisms underlying this activity currently remain unclear.
Externí odkaz:
https://doaj.org/article/ad7e64ff3a7e4adab1e9b9eca882b95a
Autor:
Shunichi Takeda, Matthew J. Longley, Masataka Tsuda, Keizo Tano, Rajendra Prasad, Hiroyuki Sasanuma, William C. Copeland, Rachel Krasich, Melike Çağlayan, Kei Kadoda, Samuel H. Wilson
Publikováno v:
Nucleic Acids Research
Mitochondrial aprataxin (APTX) protects the mitochondrial genome from the consequence of ligase failure by removing the abortive ligation product, i.e. the 5′-adenylate (5′-AMP) group, during DNA replication and repair. In the absence of APTX act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28b8bbaffd817445f97fae849a559b77
https://doi.org/10.1093/nar/gkx654
https://doi.org/10.1093/nar/gkx654
Autor:
Hiroyuki Sasanuma, Koji Kobayashi, Toshiki Tsurimoto, Ryo Fujisawa, Shunichi Takeda, Kei Kadoda, Masato Ooka, Shar Yin Naomi Huang, Kazuhiro Terada, Kouji Hirota, Junpei Yamamoto, Julian E. Sale, Shigenori Iwai, Remi Akagawa, Masataka Tsuda, Yves Pommier
Publikováno v:
Oncotarget
// Masataka Tsuda 1 , Kazuhiro Terada 1 , Masato Ooka 2 , Koji Kobayashi 2 , Hiroyuki Sasanuma 1 , Ryo Fujisawa 3 , Toshiki Tsurimoto 3 , Junpei Yamamoto 4 , Shigenori Iwai 4 , Kei Kadoda 1, 5 , Remi Akagawa 1 , Shar-Yin Naomi Huang 6 , Yves Pommier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083df7297ce63a33dd06952485916b85
http://europepmc.org/articles/PMC5464882
http://europepmc.org/articles/PMC5464882
Autor:
Masamichi Ishiai, Shunichi Takeda, Masataka Tsuda, Takahito Moriwaki, Keizo Tano, Minoru Takata, Hiroshi Ide, Shin-ichiro Masunaga, Hiroyuki Sasanuma, Kei Kadoda
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185141 (2017)
PLoS ONE
PLoS ONE
Metformin is a biguanide drug that is widely used in the treatment of diabetes. Epidemiological studies have indicated that metformin exhibits anti-cancer activity. However, the molecular mechanisms underlying this activity currently remain unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24a6f5636e36d51b0940c5704809cb1
http://europepmc.org/articles/PMC5605006?pdf=render
http://europepmc.org/articles/PMC5605006?pdf=render
Autor:
Çaglayan, Melike, Prasad, Rajendra, Krasich, Rachel, Longley, Matthew J., Kei Kadoda, Masataka Tsuda, Hiroyuki Sasanuma, Shunichi Takeda, Keizo Tano, Copeland, William C., Wilson, Samuel H.
Publikováno v:
Nucleic Acids Research; 9/29/2017, Vol. 45 Issue 17, p10079-10088, 10p